The latest biotech news

crispr cas9 cassava crop virus resistance

News and Trends 29 Apr 2019

Viruses Evolve to Defeat CRISPR-Cas9 in Genetically-Modified Plants

Researchers found that viral pathogens can quickly evolve to overcome transgenic cassava plants expressing the bacterial weapon CRISPR-Cas9, which could have major regulatory implications. Geminiviruses are pathogens that kill off crops such as beans, cotton and cassava plants. Past efforts to breed plants that are resistant to infection have not been successful. One potential method […]

April 29, 2019 - 2 minutesmins - By Jonathan Smith

News and Trends 25 Apr 2019

UK Scientists Engineer Cell Membrane for Long-Lasting Cell Therapy

Scientists at the University of Bristol, UK, have made a cell therapy that produces a glue-like hydrogel, which could make stem cells last for longer in the body and help wound healing in conditions such as type 2 diabetes. Cell therapies have a lot of potential for healing wounds and regenerating tissue, but they also […]

April 25, 2019 - 3 minutesmins - By Jonathan Smith

News and Trends 25 Apr 2019

Horizon Europe Scheme Gets EU Parliament Approval

The proposed Horizon Europe research funding scheme, the new Horizon 2020, has had approval from the EU parliament to launch in 2021. Since 2014, the EU research initiative Horizon 2020 has been providing funding for European innovation in biotech as well as other areas of research in academia and industry. The successor program of Horizon […]

April 25, 2019 - 2 minutesmins - By Jonathan Smith

News and Trends 23 Apr 2019

Combining DNA and RNA Testing Could Improve Precision Medicine for Cancer

An international clinical trial has shown that extending cancer testing beyond genetic mutations has potential to improve the personalized treatment of cancer. In recent years, the field of precision medicine has been rapidly growing and is bringing a lot of hope to both patients and physicians, especially in the diagnosis and treatment of […]

April 23, 2019 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 18 Apr 2019

Hookipa’s €75M IPO to Fund Vaccines for Viral Infection and Cancer

The Austrian biotech Hookipa expects to raise €75M ($84M) in an IPO on the Nasdaq stock exchange to fund the phase II development of a vaccine for the virus cytomegalovirus, and the first clinical trials of its cancer vaccines. Based in Vienna, Hookipa develops vaccines based on engineered viruses called arenavirus. The company programs arenaviruses […]

April 18, 2019 - 3 minutesmins - By Jonathan Smith

genetic engineering caterpillar crop pest oxitec

News and Trends 17 Apr 2019

UK Biotech Uses Genetic Engineering to Control Crop Munching Caterpillars

Moth caterpillars attacking crops are the latest target of the UK company Oxitec, which uses genetic engineering to suppress the populations of crop pests and disease-carrying mosquitoes. The caterpillars of the soybean looper moth Chrysodeixis includens eat crops such as soybean, tomato and cotton across North and South America, causing problems for farmers. The caterpillars […]

April 17, 2019 - 3 minutesmins - By Jonathan Smith

News and Trends 16 Apr 2019

Male-Pattern Baldness Could See First New Treatment in over 10 Years

A skin cream developed by the Italian company Cassiopea has reduced male-pattern baldness for up to 12 months in a phase II trial. Androgenetic alopecia, commonly known as male-pattern baldness in men, is a very common condition where excess male hormones (androgens) in hair follicles stop hair growing on the scalp. There are only two […]

April 16, 2019 - 2 minutesmins - By Jonathan Smith

promethera liver failure stem cell therapy

News and Trends 15 Apr 2019

First Stem Cell Therapy for Liver Failure Shows Promise in First Human Trials

A stem cell therapy developed by the Belgian company Promethera has improved symptoms, such as jaundice, in patients with acute liver failure, a condition with no effective treatments. A phase I/IIa trial of the therapy recruited 19 patients with chronic liver disease. Of these,12 patients had developed acute-on-chronic liver failure, a life-threatening syndrome where the […]

April 15, 2019 - 2 minutesmins - By Jonathan Smith

sophia genetics ai genomics cancer diagnostic

News and Trends 11 Apr 2019

Swiss Multi-Cancer Diagnostic Test Approved in Europe

A cancer test developed by the Swiss company SOPHiA GENETICS has been approved for diagnosing multiple types of solid tumors by looking at genetic variations in 42 genes. SOPHiA GENETICS works in data-driven medicine, using huge amounts of genomic data to diagnose and personalize treatments to a patient. This new technology is being adopted by […]

April 11, 2019 - 2 minutesmins - By Jonathan Smith

bubonic plague y pestis enesi pharma university of Oxford feal

News and Trends 10 Apr 2019

Needle-Free Vaccine for Bubonic Plague to be Developed in the UK

The UK biotech Enesi Pharma has joined forces with researchers from the University of Oxford to develop a vaccine for the bubonic plague that is simple to use and doesn’t require needles. Caused by the bacteria Yersinia pestis, the bubonic plague is infamous for having killed over 50 million Europeans in the Middle Ages. While […]

April 10, 2019 - 2 minutesmins - By Jonathan Smith

News and Trends 9 Apr 2019

French First-in-Class Diabetes Drug Nails Phase III Trial

An oral first-in-class drug targeting the mitochondria, developed by the French biotech Poxel, has shown big potential for treating type 2 diabetes in a phase III trial in Japan. Poxel’s lead candidate drug imeglimin has taken a step closer to entering the huge market for diabetes type 2 treatments. In a phase III trial in […]

April 9, 2019 - 3 minutesmins - By Jonathan Smith

News and Trends 8 Apr 2019

AACR 2019: European Biotech Progresses in Fighting Cancer

The American Association for Cancer Research (AACR) met up in Atlanta, USA, to showcase the newest advances in cancer treatment from around the world. Sit back as we give you a quick rundown of the most interesting presentations from European organizations working to improve the treatment of cancer. Clinical trials In the conference last […]

April 8, 2019 - 4 minutesmins - By Jonathan Smith

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

News and Trends

Viruses Evolve to Defeat CRISPR-Cas9 in Genetically-Modified Plants

UK Scientists Engineer Cell Membrane for Long-Lasting Cell Therapy

Horizon Europe Scheme Gets EU Parliament Approval

Combining DNA and RNA Testing Could Improve Precision Medicine for Cancer

Hookipa’s €75M IPO to Fund Vaccines for Viral Infection and Cancer

UK Biotech Uses Genetic Engineering to Control Crop Munching Caterpillars

Male-Pattern Baldness Could See First New Treatment in over 10 Years

First Stem Cell Therapy for Liver Failure Shows Promise in First Human Trials

Swiss Multi-Cancer Diagnostic Test Approved in Europe

Needle-Free Vaccine for Bubonic Plague to be Developed in the UK

French First-in-Class Diabetes Drug Nails Phase III Trial

AACR 2019: European Biotech Progresses in Fighting Cancer

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!